{"id":780744,"date":"2023-08-29T12:17:30","date_gmt":"2023-08-29T16:17:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/"},"modified":"2023-08-29T12:17:30","modified_gmt":"2023-08-29T16:17:30","slug":"viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/","title":{"rendered":"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement"},"content":{"rendered":"
\n

\n Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) — <\/strong>Viveon Health Acquisition Corp. (NYSE American: VHAQ) (\u201cViveon\u201d), a special purpose acquisition company, and Clearday, Inc. (CLRD) (\u201cClearday\u201d), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the \u201cMerger Agreement\u201d). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and into Clearday, with Clearday surviving the merger as a wholly owned subsidiary of Viveon (the \u201cMerger\u201d).<\/p>\n

The amendment to the Merger Agreement provides for, among other things, (i) an increase in the merger consideration from $250,000,000 to $500,000,000 (plus the aggregate exercise price for all Clearday options and warrants), payable in shares of Viveon\u2019s common stock, (ii) that holders of all of Clearday\u2019s capital stock (including Clearday\u2019s common stock and preferred stock) at the effective time of the Merger will be entitled to receive a pro rata portion of the earnout shares, and (iii) amending the mechanics for appointing a successor Clearday representative.<\/p>\n

\u201cWe continue to believe Clearday to be the right partner for Viveon and look forward to closing the transaction in the near future,\u201d said Jagi Gill, CEO of Viveon. Mr Gill added, \u201cWe have been working closely with the Clearday team during the last few months to further develop their longevity-tech platform and believe Clearday has added considerably to the platform\u2019s ability to meet the significant addressable longevity care market that is estimated to be more than $275 billion and provide meaningful benefits to residential care communities and their staff. We remain committed to working with the Clearday team to optimize their novel technology platform and executing on the sales channel expansion delivering companion care solutions for residents and operators in the burgeoning senior care market.\u201d<\/p>\n

Jim Walesa, CEO of Clearday, stated, \u201cWe appreciate working with Viveon to better transition Clearday into a high-growth technology business serving the pressing and expensive longevity care crisis facing our aging population. Clearday\u2019s care solutions combine AI-enabled robotics and a software platform that enables autonomous companionship, care intelligence, and a patient data platform to address the challenges in the longevity care market with proven results in our communities.\u201d<\/p>\n

Additional information about the proposed transaction, including a copy of the amendment to the Merger Agreement, can be found in a Current Report on Form 8-K to be filed each of Viveon and Clearday with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d) and will be available at www.sec.gov<\/a>.<\/p>\n

\n Advisors<\/strong>\n <\/p>\n

Dykema Gossett PLLC is acting as legal counsel to Clearday.<\/p>\n

Loeb and Loeb LLP is acting as legal counsel to Viveon.<\/p>\n

ClearThink Capital LLC is acting as a transactional and strategic advisor to the parties.<\/p>\n

\n About Clearday Inc.<\/strong>\n <\/p>\n

Clearday\u2122<\/sup>\u00a0is an innovative longevity healthcare technology company with a modern, hopeful vision for making high-quality care solutions more accessible, affordable, and empowering for aging individuals and their families. Clearday has a decades-long experience in non-acute care through its subsidiary, which operates highly-rated residential memory care and adult daycare communities. Its Longevity Care Platform brings Clearday solutions to people wherever they are. Its platform is at the intersection of telehealth, remote monitoring, and patient engagement \u2014 all delivered across mobile, and robotic endpoints in a Software-as-a-Service (SaaS) and Robotics as a Service (RaaS) model. Learn more about Clearday and its pioneering legislative efforts to bring the \u201cInnovative Cognitive Care Act for Veterans\u201d to Congress at www.myclearday.com\/viveon\/<\/a>.\u00a0<\/p>\n

\n About Viveon Health Acquisition Corp.<\/strong>\n <\/p>\n

Viveon Health Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is Viveon\u2019s intention to pursue prospective targets that are focused on the healthcare sector in the United States and other developed countries.<\/p>\n

\n Important Information About the Proposed Business Combination and Where to Find It<\/strong>\n <\/p>\n

In connection with the proposed business combination, Viveon and Clearday intend to file relevant materials with the SEC, including a registration statement on Form S-4 containing a joint preliminary proxy statement\/prospectus (the \u201cForm S-4\u201d) with the SEC and after the registration statement is declared effective, each of Viveon and Clearday will mail a definitive proxy statement\/final prospectus relating to the proposed business combination to their respective stockholders.<\/p>\n

The Form S-4 will include a joint proxy statement to be distributed to (i) holders of Viveon\u2019s common stock in connection with the solicitation of proxies for the vote by Viveon\u2019s stockholders, and (ii) holders of Clearday\u2019s common stock in connection with the solicitation of proxies for the vote by Clearday\u2019s stockholders with respect to the proposed transaction and other matters as described in the Form S-4, as well as the prospectus relating to the offer of securities to be issued to Clearday\u2019s stockholders in connection with the proposed business combination. After the Form S-4 has been filed and declared effective, each of Viveon and Clearday will mail a definitive proxy statement\/prospectus, when available, to their respective stockholders. Investors, security holders and other interested parties are urged to read the Form S-4, any amendments thereto and any other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about Viveon, Clearday and the proposed business combination. Additionally, each of Viveon and Clearday will file other relevant materials with the SEC in connection with the proposed business combination. Copies may be obtained free of charge at the SEC\u2019s web site at www.sec.gov<\/a><\/em>. The documents filed by Viveon with the SEC also may be obtained free of charge upon written request to Viveon at: 3480 Peachtree Road NE, 2nd Floor – Suite #112 Atlanta, Georgia 30326. The documents filed by Clearday with the SEC also may be obtained free of charge upon written request to Clearday at: 8800 Village Drive, Suite 106, San Antonio, Texas 78217.<\/p>\n

Security holders of Viveon and security holders of Clearday are urged to read the Form S-4 and the other relevant materials when they become available before making any voting decision with respect to the proposed business combination because they will contain important information about the business combination and the parties to the business combination. The information contained on, or that may be accessed through, the websites referenced in this Press Release (this \u201cPress Release\u201d) is not incorporated by reference into, and is not a part of, this Press Release.<\/p>\n

\n Participants in the Solicitation<\/strong>\n <\/p>\n

Viveon and its directors and executive officers may be deemed participants in the solicitation of proxies from Viveon\u2019s and Clearday\u2019s stockholders with respect to the business combination. A list of the names of those directors and executive officers and a description of their interests in Viveon will be included in the Form S-4 for the proposed business combination and be available at www.sec.gov<\/a><\/em>. Additional information regarding the interests of such participants will be contained in the proxy statement\/prospectus for the proposed business combination when available. Information about Viveon\u2019s directors and executive officers and their ownership of Viveon\u2019s common stock is set forth in Viveon\u2019s Annual Report on Form 10-K for the year ended December 31, 2022 and filed with the SEC on August 24, 2023, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. Other information regarding the direct and indirect interests of the participants in the proxy solicitation will be included in the proxy statement\/prospectus pertaining to the proposed business combination when it becomes available. These documents can be obtained free of charge from the SEC\u2019s web site at www.sec.gov<\/em><\/a>.<\/p>\n

Clearday and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of Viveon and Clearday in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be included in the Form S-4 for the proposed business combination. Information about Clearday\u2019s directors and executive officers and their ownership in Clearday is set forth in Clearday\u2019s Annual Report on Form 10-K for the year ended December 31, 2022 and filed with the SEC on May 25, 2023, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

Certain statements made in this Press Release are \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as \u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cwill,\u201d \u201cshall,\u201d \u201cmay,\u201d \u201canticipate,\u201d \u201cassume,\u201d \u201cestimate,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cpositioned,\u201d \u201cfuture,\u201d \u201cforecast,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201coutlook\u201d and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Examples of forward-looking statements include, among others, statements made in this Press Release regarding: the proposed transactions contemplated by the Merger Agreement, including the benefits of the proposed business combination, integration plans, expected synergies and revenue opportunities; anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, continued expansion of product portfolios and the availability or effectiveness of the technology for such products; the longevity health care sector\u2019s continued growth; and the expected timing of the proposed business combination. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Viveon\u2019s and Clearday\u2019s current beliefs, expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, the following: (1) the occurrence of any event, change, or other circumstances that could give rise to the termination of the Merger Agreement; (2) the institution or outcome of any legal proceedings that may be instituted against Viveon and\/or Clearday following the announcement of the Merger Agreement and the transactions contemplated therein; (3) the inability of the parties to complete the proposed business combination, including due to failure to obtain approval of the stockholders of Viveon or Clearday, certain regulatory approvals, or satisfy other conditions to closing in the Merger Agreement; (4) the occurrence of any event, change, or other circumstance that could give rise to the termination of the Merger Agreement or could otherwise cause the transaction to fail to close; (5) the impact of COVID-19 pandemic on Clearday\u2019s business and\/or the ability of the parties to complete the proposed business combination; (6) the inability to obtain or maintain the listing of Viveon\u2019s shares of common stock on the NYSE American following the proposed business combination; (7) the risk that the proposed business combination disrupts current plans and operations as a result of the announcement and consummation of the proposed business combination; (8) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition and the ability of Clearday to grow and manage growth profitably and retain its key employees; (9) costs related to the proposed business combination; (10) changes in applicable laws or regulations; (11) the possibility that Clearday may be adversely affected by other economic, business, and\/or competitive factors; (12) the amount of redemption requests made by Viveon\u2019s stockholders; and (13) other risks and uncertainties indicated from time to time in the final prospectus of Viveon for its initial public offering dated December 22, 2020 filed with the SEC, Viveon\u2019s Annual Report on Form 10-K, Clearday\u2019s Annual Report on Form 10-K and the Form S-4 relating to the proposed business combination, including those under \u201cRisk Factors\u201d therein, and in Viveon s and Clearday\u2019s other filings with the SEC. The foregoing list of factors is not exclusive and Viveon and Clearday caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Viveon and Clearday do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions, or circumstances on which any such statement is based, whether as a result of new information, future events, or otherwise, except as may be required by applicable law. Neither Viveon nor Clearday gives any assurance that the combined company will achieve its expectations.<\/p>\n

\n No Offer or Solicitation<\/strong>\n <\/p>\n

This Press Release shall not constitute a solicitation of a proxy, consent, or authorization with respect to any securities or in respect of the proposed business combination. This Press Release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.<\/p>\n

\n Contacts:<\/strong>
\n
Viveon Health Acquisition Corporation
Chief Financial Officer
Rom Papadopoulos
rom@viveonhealth.com<\/a>
(404) 861-5393<\/p>\n

Clearday Inc.
Investor Relations
Ginny Connolly
info@myclearday.com<\/a>
210-451-0839<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp. (NYSE American: VHAQ) (\u201cViveon\u201d), a special purpose acquisition company, and Clearday, Inc. (CLRD) (\u201cClearday\u201d), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the \u201cMerger Agreement\u201d). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and into Clearday, with Clearday surviving the merger as a wholly owned subsidiary of Viveon … <\/p>\n

Continue reading “Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780744","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nViveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp. (NYSE American: VHAQ) (\u201cViveon\u201d), a special purpose acquisition company, and Clearday, Inc. (CLRD) (\u201cClearday\u201d), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the \u201cMerger Agreement\u201d). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and into Clearday, with Clearday surviving the merger as a wholly owned subsidiary of Viveon … Continue reading "Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-29T16:17:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement\",\"datePublished\":\"2023-08-29T16:17:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/\"},\"wordCount\":2318,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/\",\"name\":\"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==\",\"datePublished\":\"2023-08-29T16:17:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/","og_locale":"en_US","og_type":"article","og_title":"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - Market Newsdesk","og_description":"Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp. (NYSE American: VHAQ) (\u201cViveon\u201d), a special purpose acquisition company, and Clearday, Inc. (CLRD) (\u201cClearday\u201d), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the \u201cMerger Agreement\u201d). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and into Clearday, with Clearday surviving the merger as a wholly owned subsidiary of Viveon … Continue reading \"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-29T16:17:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement","datePublished":"2023-08-29T16:17:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/"},"wordCount":2318,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/","name":"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==","datePublished":"2023-08-29T16:17:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAwMiM1Nzg4ODk3IzUwMDExMDQ4OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viveon-health-acquisition-corp-and-clearday-inc-announce-amendment-to-their-definitive-merger-agreement-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780744"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780744\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}